Salbutamol Syrup Supplier India, Salbot Syrup Franchise, Bronchodilator Syrup Distributor, Salbutamol Syrup Manufacturer, Asthma Medicine Supplier, Respiratory Therapy Syrup Exporter, PCD Pharma Respiratory Range

Bronchodilator Syrup Supplier in Mumbai

Salbutamol Syrup Distributor in Delhi

Respiratory Therapy Syrup Franchise Opportunity in Bangalore

Salbutamol Syrup Stockist in Hyderabad
Salbutamol Syrup Stockist in Hyderabad

Home/Products /salbutamol-2mg-5ml-syrup

Salbot Syrup

Composition : Salbutamol (2mg/5ml) Syrup

Dosage Form : Syrup

Packaging Type : Bottle

Packaging : 60ml

Price : ₹1/-

Salbot Syrup contains Salbutamol 2mg/5ml, a fast-acting bronchodilator syrup designed to manage asthma, bronchospasm, and other respiratory conditions. It helps in relieving wheezing, shortness of breath, chest tightness, and coughing.

Salbutamol acts on beta-2 adrenergic receptors, relaxing airway smooth muscles for rapid symptom relief. Syrup form ensures accurate dosing, better compliance, and ease of administration, especially for pediatric and adolescent patients.

Salbot Syrup is widely recommended in hospitals, clinics, and pharmacies as a high-demand respiratory therapy.

Adding Salbot Syrup to your respiratory portfolio enhances your product range with a clinically trusted, fast-moving bronchodilator. Its prescriber confidence, pediatric suitability, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Read More

About the Product

Salbot Syrup contains Salbutamol 2mg/5ml, a fast-acting bronchodilator syrup designed to manage asthma, bronchospasm, and other respiratory conditions. It helps in relieving wheezing, shortness of breath, chest tightness, and coughing.

Salbutamol acts on beta-2 adrenergic receptors, relaxing airway smooth muscles for rapid symptom relief. Syrup form ensures accurate dosing, better compliance, and ease of administration, especially for pediatric and adolescent patients.

Salbot Syrup is widely recommended in hospitals, clinics, and pharmacies as a high-demand respiratory therapy.

Adding Salbot Syrup to your respiratory portfolio enhances your product range with a clinically trusted, fast-moving bronchodilator. Its prescriber confidence, pediatric suitability, and export potential make it ideal for PCD pharma companies, distributors, and third-party manufacturing partners.

Common side effects may include tremors, nervousness, headache, palpitations, or mild dizziness. Rare but serious side effects include chest pain, irregular heartbeat, or severe allergic reactions. Medical attention should be sought if severe or persistent symptoms occur.

Salbot Syrup is indicated for the relief and management of bronchial asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions associated with reversible airway obstruction, as prescribed by a healthcare professional.

Salbot Syrup should be taken strictly as prescribed, using a proper measuring device. Do not exceed the recommended dose. Caution is advised in patients with heart disease, hypertension, diabetes, or thyroid disorders. Inform the doctor about any other medications being taken.

Store Salbot Syrup in a cool, dry place away from direct sunlight. Keep the bottle tightly closed, out of reach of children, and do not use beyond the expiry date mentioned on the label.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation